Table 3 Analysis of laboratory indexes between non-fatal group and fatal group
Non-fatal group (N = 85) | Fatal group (N = 39) | P-value | ||
|---|---|---|---|---|
SFTSV | (TCID 50/ml) | 3630 (818–14,700) | 98,450 (33,750–464,500) | 0.000* |
WBC | (G/L) | 2.89 (1.87–4.35) | 2.14 (1.575–4.335) | 0.426 |
N | (G/L) | 1.685 (0.75–2.78) | 1.365 (0.82–2.645) | 0.901 |
E | (G/L) | 0 (0–0) | 0 (0–0.01) | 0.327 |
L | (G/L) | 0.745 (0.53–1.12) | 0.545 (0.32–0.895) | 0.019* |
M | (G/L) | 0.19 (0.08–0.44) | 0.085 (0.03–0.21) | 0.001* |
PLT | (G/L) | 38 (29–46) | 35 (24–48) | 0.222 |
ALT | (G/L) | 102 (54–162) | 140.5 (73.5–203.5) | 0.039* |
AST | (G/L) | 277 (160–457) | 386 (293–677.5) | 0.015* |
ALP | (U/L) | 68 (51–100) | 67 (55.5–103.5) | 0.808 |
ALB | (g/l) | 29.15 (27.2–31.8) | 28.9 (26.55–31.45) | 0.554 |
CysC | (mg/L) | 1.08 (0.87–1.32) | 1.6 (1.33–1.825) | 0.000* |
BUN | (mmol/L) | 4.49 (2.8–6.57) | 7.165 (6.2–10.03) | 0.000* |
Cr | (μmol/L) | 64.85 (57.9–81.4) | 84.6 (62.55–126.7) | 0.005* |
UA | (μmol/L) | 231.9 (156.7–289) | 275.95 (209.25–378.65) | 0.011* |
GFR | ml/min/1.71 m2 | 98.3 (83.4–106.2) | 75.1 (50.5–99.3) | 0.001* |
D-D | (mg/L) | 3.555 (1.74–5.42) | 3.68 (2.31–9.795) | 0.137 |
PT | (s) | 12.7 (12.2–13.5) | 13.45 (12.6–14.7) | 0.004* |
APTT | (s) | 54.6 (47.2–65.8) | 65.05 (54.5–85.95) | 0.000* |
FIB | (g/l) | 2.62 (2.22–3.1) | 2.5 (2.105–2.865) | 0.184 |
INR | 0.96 (0.93–1.05) | 1.05 (0.95–1.17) | 0.020* | |
CK | (U/L) | 937.5 (391–2114) | 1029 (634.5–2094) | 0.738 |
LDH | (U/L) | 1155.5 (727–1665) | 1348 (878.5–1820) | 0.227 |